New EMA Draft Guideline on Clinical Evaluation of Vaccines

Comments can be sent in until 30th October 2018

This guideline addresses the clinical evaluation of vaccines intended for the prevention of infectious diseases. It includes considerations for trials intended to document the safety, immunogenicity and efficacy of new candidate vaccines and to support changes in the prescribing information of licensed vaccines. It also considers the need for and use of vaccine effectiveness studies.

Read the pdf
Copyright Widler & Schiemann AG 2015. All Rights Reserved. /